Towards novel processes for the fine-chemical and pharmaceutical industries.
In response to the need in the pharmaceutical industry for more complex, chiral molecules, fine-chemical companies are embracing new manufacturing technologies to produce compounds of these specifications. In particular, recent developments in biocatalysis combined with novel process engineering are providing improved methods for the production of valuable chemical intermediates.
D002384:Catalysis; D002617:Chemical Industry / Q000379:methods* / Q000639:trends; D019020:Directed Molecular Evolution; D004345:Drug Industry / Q000379:methods* / Q000639:trends; D004798:Enzymes / Q000096:biosynthesis* / Q000138:chemical synthesis*; D015202:Protein Engineering / Q000379:methods* / Q000639:trends
D004798:Enzymes